[1]Perry A, Wesseling P. Histologic classification of gliomas[J]. Handb Clin Neurol, 2016, 134: 71-95.
[2]Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820.
[3]Roumeliotis TI, Williams SP, Gonalves E, et al. Genomic determinants of protein abundance variation in colorectal cancer cells[J]. Cell Rep, 2017, 20(9): 2201-2214.
[4]Mounier C, Bouraoui L, Rassart E. Lipogenesis in cancer progression (review)[J]. Int J Oncol, 2014, 45(2): 485-492.
[5]Wang C, Rajput S, Watabe K, et al. Acetyl-CoA carboxylase-a as a novel target for cancer therapy[J]. Front Biosci (Schol Ed), 2010, 2: 515-526.
[6]Yahagi N, Shimano H, Hasegawa K, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma[J]. Eur J Cancer, 2005, 41(9): 1316-1322.
[7]Rios Garcia M, Steinbauer B, Srivastava K, et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence[J]. Cell Metab, 2017, 26(6): 842-855.
[8]Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8): 649-658.
[9]Li G, Zhang Z, Wang R, et al. Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest[J]. J Exp Clin Cancer Res, 2013, 32(1): 20.
[10]Yu XH, Ren XH, Liang XH, et al. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (review) [J]. Mol Med Rep, 2018, 18(6): 5307-5316.
[11]Ye B, Yin L, Wang Q, et al. ACC1 is overexpressed in liver cancers and contributes to the proliferation of human hepatoma Hep G2 cells and the rat liver cell line BRL 3A[J]. Mol Med Rep, 2019, 19(5): 3431-3440.
[12]Li EQ, Zhao W, Zhang C, et al. Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors[J]. Eur J Pharm Sci, 2019, 137: 105010.
[13]Jones JE, Esler WP, Patel R, et al. Inhibition of acetyl-coA carboxylase 1 (ACC1) and 2 (ACC2) reduces proliferation and De novo lipogenesis of EGFRvⅢ human glioblastoma cells[J]. PLoS One, 2017, 12(1): e0169566.
[14]Wellen KE, Thompson CB. A two-way street: reciprocal regulation of metabolism and signaling[J]. Nat Rev Mol Cell Biol, 2012, 13(4): 270-276.
[15]Kuchta K, Towpik J, Biernacka A, et al. Predicting proteome dynamics using gene expression data[J]. Sci Rep, 2018, 8(1): 13866.
[16]Costanzo M, Kuzmin E, Leeuwen JV, et al. Global genetic networks and the genotype-to-phenotype relationship[J]. Cell, 2019, 177(1): 85-100.
[17]Galdieri L, Vancura A. Acetyl-CoA carboxylase regulates global histone acetylation[J]. J Biol Chem, 2012, 287(28): 23865-23876.
[18]Chow JD, Lawrence RT, Healy ME, et al. Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation[J]. Mol Metab, 2014, 3(4): 419-431.
[19]Ouédraogo ZG, Biau J, Kemeny JL, et al. Role of STAT3 in genesis and progression of human malignant gliomas[J]. Mol Neurobiol, 2017, 54(8): 5780-5797.
[20]Rébé C, Ghiringhelli F. STAT3, a master regulator of anti-tumor immune response[J]. Cancers (Basel), 2019, 11(9): 1280.
[21]Wang J, Yang Y, Yang N, et al. Expression of phosphorylated-signal transduction and activator of transcription 3 (Y705) in adenomyosis and their clinical significances[J]. Acta Anatomica Sinica, 2016, 47(2):261-267. (in Chinese)
王静,杨阳,杨宁,等. 磷酸化信号转导和转录激活因子3(Y705)在子宫腺肌症中的表达及其临床意义[J]. 解剖学报,2016,47(2): 261-267.
[22]Piperi C, Papavassiliou KA, Papavassiliou AG. Pivotal role of STAT3 in shaping glioblastoma immune microenvironment[J]. Cells, 2019, 8(11): 1398.
[23]Avalle L, Camporeale A, Camperi A, et al. STAT3 in cancer: a double edged sword[J]. Cytokine, 2017, 98: 42-50.
[24]Sestito R, Madonna S, Scarponi C, et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation[J]. FASEB J, 2011, 25(3): 916-927.
[25]Lv D, Li Y, Zhang W, et al. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma[J]. Nat Commun, 2017, 8(1): 1454.
|